Methodological Approaches to Real-World Evidence Generation for Glucagon-like Peptide-1-Based Therapies: Synopsis of a National Institute of Diabetes and Digestive and Kidney Diseases Workshop

By afschroeder • June 30, 2026

Curtis LH, Arterburn D, Toh S, Guo J, Hernán MA, Iturralde E, Jastreboff A, Lewis KH, Lund JL, Maciejewski ML, McCoy RG, McTigue KM, Narain K, Wee CC, Osganian SK, Hales C. Methodological Approaches to Real-World Evidence Generation for Glucagon-like Peptide-1-Based Therapies: Synopsis of a National Institute of Diabetes and Digestive and Kidney Diseases Workshop. Ann Intern Med. 2026 Jun 30. doi: 10.7326/ANNALS-26-00202. Epub ahead of print. PMID: 42372277.

Tags: General Internal Medicine, Publications

Contemporary Diabetes Technology and the Patient Experience

Everett EM, Shaw E, Escobar Barrios B, Moin T, Wisk LE. Contemporary Diabetes Technology and the Patient Experience. JAMA Netw Open. 2026 Jul 1;9(7):e2624260. doi:[...]

Sustained Reduction of Elevated Intact Parathyroid Hormone Concentrations with Extended-Release Calcifediol Slows Chronic Kidney Disease Progression in Secondary Hyperparathyroidism Patients

Bishop CW, Ashfaq A, Strugnell SA, Choe J, Patel N, Norris KC, Sprague SM. Sustained Reduction of Elevated Intact Parathyroid Hormone Concentrations with Extended-Release Calcifediol[...]

Practice Pattern and Outcome Differences in the Emergency Department by Physician Sex

Ly DP, Coussens S, Burke LG. Practice Pattern and Outcome Differences in the Emergency Department by Physician Sex. JAMA Intern Med. 2026 Jul 20. doi:[...]